Search research articles
Contact Us
Filters
Showing results (201-210 of 426) with videos related to
Page
of 43
Sort By:
Diabetologia
|
September 15, 2023
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells
Benedetta Maria Bonora, Mario Luca Morieri, Marella Marassi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 5, 2023
Noninvasive Indices of MASLD Are Associated With Hypogonadism in Male Patients With Type 2 Diabetes Mellitus
Nicola Caretta, Raffaele Scafa, Andrea Graziani, et al.
International Journal of Environmental Research and Public Health
|
November 26, 2022
Assessment of Glucose Lowering Medications' Effectiveness for Cardiovascular Clinical Risk Management of Real-World Patients with Type 2 Diabetes: Targeted Maximum Likelihood Estimation under Model Misspecification and Missing Outcomes
Veronica Sciannameo, Gian Paolo Fadini, Daniele Bottigliengo, et al.
The Lancet Regional Health. Europe
|
February 8, 2024
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk
Gian Paolo Fadini, Enrico Longato, Mario Luca Morieri, et al.
Diabetes Research and Clinical Practice
|
February 28, 2025
Exploring the benefits of alirocumab as lipid-lowering therapy in people with diabetes and very high cardiovascular risk
Angelo Avogaro, Raffaella Buzzetti, Riccardo Candido, et al.
Diabetes Care
|
December 29, 2007
Maternal insulin therapy increases fetal endothelial progenitor cells during diabetic pregnancy
Gian Paolo Fadini, Ilenia Baesso, Carlo Agostini, et al.
Diabetes
|
March 2, 2002
Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes
Roldano Scognamiglio, Angelo Avogaro, Saula Vigili de Kreutzenberg, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 15, 2017
Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus
Marc Evans, Plamen Kozlovski, Päivi M Paldánius, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
June 8, 2022
Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational Study
Benedetta Maria Bonora, Roberta Cappellari, Marco Grasso, et al.
Cardiovascular Diabetology
|
January 19, 2018
p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications
Gian Paolo Fadini, Mattia Albiero, Benedetta Maria Bonora, et al.
Page
of 43
Search research articles
Search
Showing results (201-210 of 426) with videos related to
Sort By:
Page
of 43
Diabetologia
|
September 15, 2023
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells
Benedetta Maria Bonora, Mario Luca Morieri, Marella Marassi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 5, 2023
Noninvasive Indices of MASLD Are Associated With Hypogonadism in Male Patients With Type 2 Diabetes Mellitus
Nicola Caretta, Raffaele Scafa, Andrea Graziani, et al.
International Journal of Environmental Research and Public Health
|
November 26, 2022
Assessment of Glucose Lowering Medications' Effectiveness for Cardiovascular Clinical Risk Management of Real-World Patients with Type 2 Diabetes: Targeted Maximum Likelihood Estimation under Model Misspecification and Missing Outcomes
Veronica Sciannameo, Gian Paolo Fadini, Daniele Bottigliengo, et al.
The Lancet Regional Health. Europe
|
February 8, 2024
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk
Gian Paolo Fadini, Enrico Longato, Mario Luca Morieri, et al.
Diabetes Research and Clinical Practice
|
February 28, 2025
Exploring the benefits of alirocumab as lipid-lowering therapy in people with diabetes and very high cardiovascular risk
Angelo Avogaro, Raffaella Buzzetti, Riccardo Candido, et al.
Diabetes Care
|
December 29, 2007
Maternal insulin therapy increases fetal endothelial progenitor cells during diabetic pregnancy
Gian Paolo Fadini, Ilenia Baesso, Carlo Agostini, et al.
Diabetes
|
March 2, 2002
Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes
Roldano Scognamiglio, Angelo Avogaro, Saula Vigili de Kreutzenberg, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 15, 2017
Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus
Marc Evans, Plamen Kozlovski, Päivi M Paldánius, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
June 8, 2022
Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational Study
Benedetta Maria Bonora, Roberta Cappellari, Marco Grasso, et al.
Cardiovascular Diabetology
|
January 19, 2018
p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications
Gian Paolo Fadini, Mattia Albiero, Benedetta Maria Bonora, et al.
Page
of 43